UPB – upstream bio, inc. (US:NASDAQ)
Stock Stats
News
Upstream Bio (NASDAQ:UPB) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Upstream Bio (NASDAQ:UPB) was given a new $51.00 price target on by analysts at Mizuho.
Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study [Seeking Alpha]
Upstream Bio (NASDAQ:UPB) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $43.00 price target on the stock.
Upstream Bio (UPB): Evaluating Valuation After 10% Share Price Surge [Yahoo! Finance]
Form SCHEDULE 13G/A Upstream Bio, Inc. Filed by: TCG Crossover GP I, LLC
Form SCHEDULE 13G/A Upstream Bio, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Form S-3ASR Upstream Bio, Inc.
Form 10-Q Upstream Bio, Inc. For: Sep 30
Form 8-K Upstream Bio, Inc. For: Nov 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.